共 141 条
[1]
Anghileri M(2006)Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution Cancer 107 1065-1074
[2]
Miceli R(2007)The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97-109
[3]
Fiore M(2001)Malignant peripheral nerve sheath tumours–report of 8 cases and review of the literature Acta Neurochir (Wien) 143 357-363
[4]
Mariani L(2010)Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign Cancer 116 451-458
[5]
Ferrari A(2008)[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study Ann Oncol 19 390-394
[6]
Mussi C(2010)Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma Ann Surg Oncol 17 115-122
[7]
Louis DN(2005)Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 61 1385-1392
[8]
Ohgaki H(2007)Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer Int J Radiat Oncol Biol Phys 69 1282-1289
[9]
Wiestler OD(2007)Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging Radiology 245 839-847
[10]
Cavenee WK(1997)Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations AJR Am J Roentgenol 169 1675-1680